The Five-Year Prospective Study of Quality of Life in Hemifacial Spasm Treated with Abo-Botulinum Toxin A

The Five-Year Prospective Study of Quality of Life in Hemifacial Spasm Treated with Abo-Botulinum Toxin A

This study aimed to determine the long-term quality of life (QoL) in hemifacial spasm (HFS) patients after treating with Abo-botulinum toxin A (Abo-BTX). The study assessed the disease-specific QoL (hemifacial spasm questionnaire 30 items; HFS 30), the involuntary movements (abnormal involuntary mov...

Full description

Bibliographic Details
Main Authors: Subsai Kongsaengdao, Narong Maneeton, Benchalak Maneeton
Format: Article
Language:English
Published: MDPI AG 2021-03-01
Series:Toxins
Subjects:
hemifacial spasm
Abo-botulinum toxin A
the health-related quality of life
depressive disorder
36-item short form health survey
AIMS
Online Access:https://www.mdpi.com/2072-6651/13/3/215

Internet

https://www.mdpi.com/2072-6651/13/3/215

Similar Items